跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Flutiright S-250
Approved
STANDARD
Flutiright S-250
Biodeal Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ed929930d8966932
Company
Biodeal Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
ed929930d8966932
Drug Approval Philippines Name
Flutiright S-250
Product Name
Flutiright S-250
Registration Number
DRP-10105
Brand Name
Flutiright S-250
Generic Name
Salmeterol (Xinafoate) + Fluticasone Propionate
Dosage Form
Dry Powder For Inhalation In Capsule
Dosage Strength
50 mcg/250 mcg
Manufacturer
Biodeal Pharmaceuticals Pvt. Ltd.
Importer
MedEthix, Inc.,
Distributor
MedEthix, Inc.,
Issuance Date
26 July 2021
Expiry Date
18 August 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ed929930d8966932
Type
Standard
Back to Philippines FDA Approvals
Flutiright S-250 - Philippines FDA Drug Approval Details